Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 100 (1-3) , 335-339
- https://doi.org/10.1016/0304-3940(89)90709-x
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Alzheimer's disease and senile dementia: Biochemical characteristics and aspects of treatmentPsychopharmacology, 1985
- A NEW DEFINITION OF ALZHEIMER'S DISEASE: A HIPPOCAMPAL DEMENTIAThe Lancet, 1985
- Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicidesNeuropharmacology, 1984
- Serotonin Receptor Changes in Dementia of the Alzheimer TypeJournal of Neurochemistry, 1984
- Changes of Biogenic Amines and Their Metabolites in Postmortem Brains from Patients with Alzheimer‐Type DementiaJournal of Neurochemistry, 1984
- Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-typeJournal of the Neurological Sciences, 1984
- Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's DiseaseJournal of Neurochemistry, 1983
- ALZHEIMER'S DISEASE AS A DISORDER OF ISODENDRITIC COREThe Lancet, 1982
- Reduced dopamine-beta-hydroxylase activity in Alzheimer's diseaseBMJ, 1981
- Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer TypeThe British Journal of Psychiatry, 1979